中国P站

Transplant Pathology; Histopathology; Solid Organ Transplantation; Rejection; Graft Injury; Antibody-Mediated Rejection; Chronic Lung Allograft Dysfunction; BK Virus Nephropathy; Non-Invasive Biomarkers; Molecular Pathology

Introduction

The field of transplant pathology is a cornerstone of solid organ transplantation, offering critical insights into graft health and function. Advances in this discipline are continually refining our understanding of rejection and injury mechanisms, guiding clinical management and ultimately improving patient outcomes. Early diagnostic challenges in solid organ transplantation necessitate a deep dive into histopathological examination, a practice that remains central to effective care [1].

The evolution of diagnostic criteria, particularly for antibody-mediated rejection in kidney allografts, highlights the dynamic nature of the field and the need for precise interpretation of histological features according to established classifications such as the Banff system [2].

In liver transplantation, understanding the pathological manifestations of early graft dysfunction is paramount for timely intervention and salvage therapies, with specific histological patterns helping to differentiate causes like primary non-function or ischemic cholangiopathy [3].

The complexities extend to heart transplantation, where the pathogenesis of chronic antibody-mediated rejection involves donor-derived alloreactive T cells and is characterized by specific histological markers and emerging molecular signatures that predict graft fibrosis and failure [4].

Similarly, in lung transplantation, the histopathological assessment of chronic lung allograft dysfunction (CLAD) is crucial for distinguishing various phenotypes and guiding management, as specific findings carry significant prognostic weight [5].

Kidney transplant recipients are also susceptible to viral complications, such as BK virus nephropathy, where characteristic histological findings and diagnostic methods are essential for early detection and to mitigate the risk of graft loss [6].

Beyond common solid organs, the pathology of small bowel transplantation presents its own unique set of challenges, with histopathology playing a vital role in diagnosing acute rejection, infection, and graft-versus-host disease, impacting graft function and survival [7].

The drive for more accurate and less invasive diagnostic methods is leading to the exploration of non-invasive biomarkers, which promise to complement traditional histopathology and potentially reduce the reliance on biopsies for monitoring allograft status [8].

Cardiac allograft vasculopathy (CAV), a significant cause of late graft loss in heart transplantation, requires meticulous pathological diagnosis to differentiate it from other coronary artery diseases and to inform prognosis, with surveillance biopsies playing a role in early detection [9].

The ongoing integration of advanced techniques, including immunohistochemistry and molecular pathology, is revolutionizing transplant pathology, enabling a more precise characterization of rejection and injury, and supporting personalized management strategies [10].

Description

Transplant pathology is integral to the successful management of solid organ transplantation, providing essential diagnostic information that shapes clinical decisions and patient prognoses. The critical role of histopathological examination in guiding management is underscored by ongoing efforts to refine diagnostic criteria and understand complex injury mechanisms [1].

In kidney transplantation, the precise identification of antibody-mediated rejection (AMR) relies on the meticulous evaluation of histological features within the framework of the Banff classification, addressing challenges in differentiating AMR from other injuries [2].

Early graft dysfunction following liver transplantation necessitates a thorough pathological review to discern causes such as primary non-function or hepatic artery thrombosis based on histological patterns, guiding crucial salvage therapies [3].

The mechanisms driving chronic antibody-mediated rejection (cAMR) in heart transplants are being elucidated through the study of donor-derived T cells and specific histological and molecular markers that contribute to graft fibrosis and accelerated failure [4].

Chronic lung allograft dysfunction (CLAD) also presents distinct pathological manifestations, and its histopathological assessment is vital for differentiating phenotypes like restrictive allograft syndrome and obstructive CLAD, with significant prognostic implications tied to specific findings [5].

In kidney transplant recipients, BK virus nephropathy (BKVN) is a significant concern, and its pathological diagnosis relies on identifying characteristic histological findings and employing specific diagnostic methods to correlate viral load and severity with graft loss risk [6].

Small bowel transplantation involves unique pathological challenges, with histopathology essential for diagnosing common complications such as acute rejection, infection, and graft-versus-host disease, all of which influence graft function and patient survival [7].

The field is increasingly exploring the utility of non-invasive biomarkers, including cell-free DNA and microRNAs, as complementary tools to traditional histopathology for detecting and monitoring allograft rejection and injury, aiming to reduce invasive procedures and improve early detection [8].

Cardiac allograft vasculopathy (CAV) remains a major determinant of late graft loss in heart transplantation, and its pathological diagnosis, including the identification of specific histological features and grading, is crucial for prognostication and guiding management, with surveillance biopsies playing a role in early identification [9].

The evolution of diagnostic approaches in transplant pathology is characterized by the integration of immunohistochemistry and molecular pathology, which enhance the precise characterization of rejection and injury, thereby supporting personalized therapeutic strategies and improved prognostication [10].

Conclusion

This collection of articles explores the critical role of pathology in solid organ transplantation. It covers advancements in understanding rejection and injury mechanisms, emphasizing histopathology's importance in diagnosis and management. Key topics include diagnostic criteria for antibody-mediated rejection in kidney transplants, pathology of early graft dysfunction in liver transplants, mechanisms of chronic rejection in heart and lung allografts, diagnosis of BK virus nephropathy, pathology of small bowel transplantation, and the emerging role of non-invasive biomarkers. The integration of molecular pathology and immunohistochemistry is highlighted as crucial for precise characterization and personalized treatment strategies. The content stresses the need for timely and accurate pathological diagnosis to improve graft survival and patient outcomes across various transplant types.

References

1. Vivette DD, Dorry LS, Enrico B. (2021) .Am J Transplant 21:1713-1725.

   , ,

2. P CR, M SS, J EC. (2020) .Transplant Rev (Orlando) 34:100553.

   , ,

3. M ES, R K, J PR. (2022) .Liver Transpl 28:724-738.

   , ,

4. S NC, P JK, J DG. (2023) .J Heart Lung Transplant 42:456-468.

   , ,

5. M EV, G MK, J LY. (2021) .Clin Chest Med 42:287-298.

   , ,

6. A SC, M TMH, K KKC. (2020) .Curr Urol Rep 21:1-9.

   , ,

7. J JL, X LZ, Y JW. (2022) .World J Gastroenterol 28:5678-5690.

   , ,

8. R SC, D RSC, S JED. (2023) .Front Immunol 14:1086740.

   , ,

9. L LRDBGSVTBKKGMMNRAM, M SMAJRVG, M LLDB. (2020) .JACC Cardiovasc Imaging 13:1379-1391.

   , ,

10. A SKFRGP, P LBSJM, L MDSC. (2021) .Curr Opin Organ Transplant 26:350-357.

    , ,